The Role of Cancer Chemotherapy in Advanced Metastatic Tumors: A Comprehensive Review

Maki Takata(Okayama University Hospital, Okayama, Japan)

Abstract

Cancer chemotherapy plays a pivotal role in the management of advanced metastatic tumors. This comprehensive review aims to explore the significance of chemotherapy in treating metastatic cancers, including its mechanisms of action, common drugs used, associated challenges, and emerging strategies. The review highlights the importance of personalized treatment approaches and the integration of chemotherapy with other therapeutic modalities to achieve optimal outcomes for patients with advanced metastatic tumors.

References

Borghi, M., Ciccarese, G., Rizzo, S., Fabi, A., Petracca, I., Cortesi, E., & Calandri, C. (2018). Chemotherapy in the palliative treatment of advanced cancer patients: where we are and where we are heading. Tumori, 104(3), 271-278.

Cancer.Net. (2021). Chemotherapy for Metastatic or Advanced Cancer.

Cortés, J., Baselga, J., & Amler, L. (2008). Mechanisms of action of taxanes and epothilones in the treatment of cancer. Oncology, 75(3), 239-251.

Daugherty, F. K., Wirth, M., Haddad, R.. (2017). Systemic therapy for advanced non-small cell lung cancer: ASCO clinical practice guidelines. Journal of the National Comprehensive Cancer Network, 15(8), 986-1007.

Ellis, L. M., & Chabner, B. A. (2012). The history of cancer chemotherapy. CA: A Cancer Journal for Clinicians, 62(2), 95-113.

Hirsch, F. R., Mazzone, P., & Cappellini, A. D. (2015). Targeting angiogenesis in the treatment of advanced nonsmall cell lung cancer. Journal of Thoracic Oncology, 10(12), 1625-1634.

Ali Raza Khaki , Shasank Chennupati, Catherine Fedorenk, Li Li, et al. . (2021). Utilization of Systemic Therapy in Patients With Cancer Near the End of Life in the Pre- Versus Postimmune Checkpoint Inhibitor Eras. JCO Oncology Practice, 17(11) , 683-1737.

Kantarjian, H., Wang, X., & Wiernik, P. H. (2017). The evolution of cytarabine in the treatment of acute myeloid leukemia. Blood, 129(1), 3-10.

Mai, S., & Pharmaceuticals, E. (2018). Microtubule-targeting agents in cancer chemotherapy. Current Opinion in Phamacology, 34, 104-113.

Mazumdar, M., & Examples, C. (2018). Targeting the PI3K/Akt/mTOR axis in cancer therapy. Cancer Treatment Reviews, 65, 1-8.

DOI: http://dx.doi.org/10.26549/jor.v5i2.15933